Health Trials

Low-grade Upper Tract Urothelial Carcinoma

2

Review clinical trials related to Low-grade Upper Tract Urothelial Carcinoma. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Phase 2A/B Efficacy and Safety of Dabogratinib in Participants With Low Grade Upper Tract Urothelial Carcinoma

A Phase 2A/B study of Dabogratinib (TYRA-300) in Low Grade Upper Tract Urothelial Carcinoma

Participants needed: 230
Trial details
Phase: Phase 2Age: 18+Biological sex: AllType: InterventionalSponsor: Tyra Biosciences, IncUpdated: Jul 2, 2026Locations: 12
Eligibility criteria

Participants ≥ 18 years of age at the time of informed consent and willing and a... [+15]

Evidence or any features of high grade (HG) UTUC [+13]

Read more
Status: Recruiting

Low-grade UTUC Treated With Nadofaragene Firadenovec Administered to Renal Pelvis

The primary purpose of this trial is to evaluate the safety \& tolerability of Nadofaragene Firadenovec in subjects with LG-UTUC. To help with this evaluation, a safety lead-in period will be conducted for the first 6 subjects. Complete response is at 3 or 6 months defined as absence of any UTUC in the renal pelvis.

Participants needed: 20
Trial details
Phase: Phase 1, Phase 2Age: 18+Biological sex: AllType: InterventionalSponsor: Ferring PharmaceuticalsUpdated: May 8, 2026Locations: 9
Eligibility criteria

Aged ≥18 years at the time of signing informed consent. [+21]

High-grade cytology or high-grade histology [+26]

Read more